Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel
Kapitza, Christoph, Nosek, Leszek, Jensen, Lene, Hartvig, Helle, Jensen, Christine B., Flint, AnneVolume:
55
Language:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.443
Date:
May, 2015
File:
PDF, 673 KB
english, 2015